SuperworthDolby Laboratories EPS DLB
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 26, 2026
- $2.35
- Latest quarter, Q3 FY26
- $0.30
- −38% on a year earlier
- Fiscal year 2025
- $2.63
- −3% on the year before
Dolby Laboratories' earnings per share was $2.35 over the twelve months to Jun 26, 2026, down 14% on a year earlier.
In its latest quarter, Q3 FY26, it was $0.30, down 38% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 3% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $2.63 | −3% |
| FY2024 | $2.70 | +31% |
| FY2023 | $2.06 | +14% |
| FY2022 | $1.80 | −39% |
| FY2021 | $2.97 | +32% |
| FY2020 | $2.25 | −8% |
| FY2019 | $2.44 | +559% |
| FY2018 | $0.37 | −81% |
| FY2017 | $1.94 | +7% |
| FY2016 | $1.81 | +3% |
| FY2015 | $1.75 | −12% |
| FY2014 | $1.98 | +8% |
| FY2013 | $1.83 | −25% |
| FY2012 | $2.45 | −11% |
| FY2011 | $2.74 | +12% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $0.30 | −38% | $2.35 | |
| Q2 FY26 | $0.99 | +5% | $2.53 | |
| Q1 FY26 | $0.55 | −21% | $2.48 | |
| Q4 FY25 | $0.51 | −15% | $2.63 | |
| Q3 FY25 | $0.48 | +20% | $2.72 | |
| Q2 FY25 | $0.94 | −7% | $2.64 | |
| Q1 FY25 | $0.70 | +1% | $2.71 | |
| Q4 FY24 | $0.60 | +567% | $2.70 | |
| Q3 FY24 | $0.40 | +135% | $2.19 | |
| Q2 FY24 | $1.01 | +3% | $1.96 | |
| Q1 FY24 | $0.69 | −16% | $1.93 | |
| Q4 FY23 | $0.09 | −68% | $2.06 |
Against its peers
Companies in Asset Management nearest Dolby Laboratories' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DLBDolby Laboratories | $2.35 | −14% a year |
| VCTRVictory Capital | $5.46 | +35% a year |
| HASIHA Sustainable Infrastructure Capital | $0.54 | −65% a year |
| HLNEHamilton Lane INC | $6.56 | +25% a year |
| MCMoelis | $2.87 | +13% a year |
| FHIFederated Hermes | $5.38 | +19% a year |
| LAZLazard | $2.04 | −29% a year |
| MORNMorningstar | $10.54 | +12% a year |
| IDCCInterDigital | $8.67 | −38% a year |
| HLIHoulihan Lokey | $5.96 | +0% a year |
| CNSCohen & Steers | $3.26 | +3% a year |
| Peer median | $5.42 |
Where Dolby Laboratories ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Dolby Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.